- Primary Results of the EVOLVE Short DAPT Study: Evaluation of 3-Month Dual Antiplatelet Therapy in High Bleeding Risk Patients Treated With a Bioabsorbable Polymer-Coated Everolimus-Eluting Stent.
Primary Results of the EVOLVE Short DAPT Study: Evaluation of 3-Month Dual Antiplatelet Therapy in High Bleeding Risk Patients Treated With a Bioabsorbable Polymer-Coated Everolimus-Eluting Stent.
Circulation. Cardiovascular interventions (2021-03-02)
Ajay J Kirtane, Robert Stoler, Robert Feldman, Franz-Josef Neumann, Loukas Boutis, Naeem Tahirkheli, Ralph Toelg, Islam Othman, Bernardo Stein, James W Choi, Stephan Windecker, Robert W Yeh, Harold L Dauerman, Matthew J Price, Paul Underwood, Dominic Allocco, Ian Meredith, Dean J Kereiakes
PMID33641374